Results 201 to 210 of about 368,924 (355)

Surface‐Coated Inorganic Nanomaterials for Drug Delivery: Chemical Design, Biomedical Applications, and Mechanistic Insights

Advanced NanoBiomed Research, EarlyView.
This review explores how surface‐coated inorganic nanomaterials are chemically engineered for advanced drug delivery. It highlights design principles, coating strategies, and biomedical applications, emphasizing how surface chemistry governs biocompatibility, targeting, and controlled release.
Hossein Daneshgar, Sepideh Ahmadi, Nikzad Abbariki, Navid Rabiee, Sidi A. Bencherif   +4 more
wiley   +1 more source

Multimodal Imaging of Ductal Carcinoma In Situ: A Single-Center Study of 75 Cases. [PDF]

Med Sci (Basel)
Urraro F, Giordano N, Patanè V, Brunese MC, Varelli C, Russo C, Brunese L, Cappabianca S.   +7 more
europepmc   +1 more source

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

, 2003
Etsuya Watanabe, Hideyasu Matsuyama, Kenji Matsuda, Chietaka Ohmi, Yasuhide Tei, Satoru Yoshihiro, Yasukazu Ohmoto, Katsusuke Naito   +7 more
openalex   +2 more sources

Detection of human papillomavirus DNA sequences by in situ DNA-DNA hybridisation in cervical intraepithelial neoplasia and invasive carcinoma: a retrospective study. [PDF]

, 1988
John Collins, David Jenkins, Dennis J. McCance   +2 more
openalex   +1 more source

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source

Management of Low-Grade Ductal Carcinoma In Situ in a Supernumerary Breast: A Case Report. [PDF]

Cureus
Bui A, Oyeniyi JF, Loving BA, Llenos J, Fontanesi J.   +4 more
europepmc   +1 more source

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. [PDF]

Sci Rep
Guo Y, Zhou X, Xu H, Wang G.
europepmc   +1 more source

Incidence of Residual Squamous Cell Carcinoma in Situ on Excision Specimens following Shave Biopsy

Devan
openalex   +2 more sources

Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis [PDF]

, 2015
Kirsty Stuart, Nehmat Houssami, Richard Taylor, Andrew Hayen, John Boyages   +4 more
openalex   +1 more source

Influence of follow-up, screening age, interval, and compliance on overdiagnosis of ductal carcinoma in situ (DCIS): A modelling study. [PDF]

PLoS One
Poelhekken K, Greuter MJW, Dorrius MD, de Bock GH.   +3 more
europepmc   +1 more source